Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | ACACB | O00763 | 5/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.35 |
| ▸ | ACSL1 | P33121 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4284205 | 0.84 | CYP3A4 (0.53) | CYP3A4ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL4289375 | 0.84 | HTR2A (0.41) | CYP3A4HTR2AACACBNAAAALDH1A1 | |
| SCHEMBL4288672 | 0.84 | SLC5A2 (0.46) | CYP3A4ALDH1A1MAPT | |
| SCHEMBL4289242 | 0.83 | CYP3A4 (0.47) | CYP3A4ALDH1A1MEN1KMT2AESR1 | |
| SCHEMBL4289255 | 0.82 | CYP3A4 (0.47) | CYP3A4NAAAALDH1A1MEN1MAPT | |
| SCHEMBL4284453 | 0.82 | THRA (0.39) | CYP3A4HTR2AACACBNAAAALDH1A1 | |
| SCHEMBL4281489 | 0.81 | ACACB (0.36) | CYP3A4HTR2AACACBNAAAALDH1A1 | |
| SCHEMBL4292887 | 0.80 | CYP3A4 (0.49) | CYP3A4ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL3999055 | 0.80 | CYP3A4 (0.49) | CYP3A4ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL4288729 | 0.80 | CYP3A4 (0.49) | CYP3A4ALDH1A1MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-2048150-A1 | BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | CYP3A4 534/4885HTR2A 910/4885ACACB 1570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.